This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kim, H.-S. Articles by Lee, C.-W. Search for Related Content PubMed PubMed Citation Articles by Kim, H.-S. Articles by Lee, C.-W.

Functional Interaction between BubR1 and Securin in an Anaphase-Promoting Complex/Cyclosome^Cdc20–Independent Manner

¹ Department of Molecular Cell Biology, Center for Molecular Medicine, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, Gyeonggi, Korea and ² Department of Pathology, Seoul National University College of Medicine, Seoul, Korea

Requests for reprints: Chang-Woo Lee, Department of Molecular Cell Biology, Center for Molecular Medicine, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon 440-746, Korea. Phone: 82-31299-6121; Fax: 82-31299-6269; E-mail: cwlee{at}med.skku.ac.kr.

Key Words: BubR1 • Securin • Anaphase-promoting complex/cyclosome • Cdc20 • Mitotic checkpoint • Chromosome segregation • Protein interactions

Activation of the mitotic checkpoint requires the precise timing and spatial organization of mitotic regulatory events, and ensures accurate chromosome segregation. Mitotic checkpoint proteins such as BubR1 and Mad2 bind to Cdc20, and inhibit anaphase-promoting complex/cyclosome^Cdc20–mediated securin degradation and the onset of anaphase. BubR1 mediates the proper attachment of microtubules to kinetochores, and links the regulation of chromosome-spindle attachment to mitotic checkpoint signaling. Therefore, disruption of BubR1 activity results in a loss of the checkpoint control, chromosome instability, and/or early onset of malignancy. In this study, we show that BubR1 directly interacts with securin in vitro and in vivo. In addition, the BubR1 interaction contributes to the stability of securin, and there is a significant positive correlation between BubR1 and securin expressions in human cancer. Importantly, BubR1 competes with Cdc20 for binding to securin, and thereby the interaction between BubR1 and securin is greatly increased by the depletion of Cdc20. Our findings may identify a novel regulation of BubR1 that can generate an additional anaphase-inhibitory signal through the Cdc20-independent interaction of BubR1 with securin. [Cancer Res 2009;69(1):27–36]